These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 15160245)

  • 1. [Best supportive care of hepatocellular carcinoma].
    Spangenberg HC; Thimme R; Von Weizsäcker F; Blum HE
    Internist (Berl); 2004 Jul; 45(7):777-85. PubMed ID: 15160245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of hepatocellular carcinoma.
    Blum HE
    Best Pract Res Clin Gastroenterol; 2005 Feb; 19(1):129-45. PubMed ID: 15757809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular targets for prevention of hepatocellular carcinoma.
    Blum HE
    Dig Dis; 2002; 20(1):81-90. PubMed ID: 12145424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The hepatocellular carcinoma: alternative therapeutical strategies].
    Spangenberg HC; Thimme R; Mohr L; Blum HE
    Zentralbl Chir; 2007 Aug; 132(4):322-7. PubMed ID: 17724635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Nonsurgical therapy methods in hepatocellular carcinoma].
    Wettstein M; Häussinger D
    Praxis (Bern 1994); 2001 Jan; 90(1-2):15-20. PubMed ID: 11206095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transarterial chemoembolization in hepatocellular carcinoma treatment: Barcelona clinic liver cancer staging system.
    Han K; Kim JH
    World J Gastroenterol; 2015 Sep; 21(36):10327-35. PubMed ID: 26420959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Nonsurgical therapy of hepatocellular carcinoma].
    Allgaier HP; Galandi D; Olschewski M; Blum HE
    Praxis (Bern 1994); 2002 Aug; 91(35):1387-92. PubMed ID: 12233280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hepatocellular carcinoma. Pathogenesis and multicentricity].
    Blum HE; Hopt UT
    Chirurg; 2003 Aug; 74(8):709-16. PubMed ID: 12928791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular therapy and prevention of hepatocellular carcinoma.
    Blum HE
    Hepatobiliary Pancreat Dis Int; 2003 Feb; 2(1):11-22. PubMed ID: 14599923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocellular carcinoma: therapy and prevention.
    Blum HE
    World J Gastroenterol; 2005 Dec; 11(47):7391-400. PubMed ID: 16437707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downstaging disease in patients with hepatocellular carcinoma outside of Milan criteria: strategies using drug-eluting bead chemoembolization.
    Green TJ; Rochon PJ; Chang S; Ray CE; Winston H; Ruef R; Kreidler SM; Glueck DH; Shulman BC; Brown AC; Durham J
    J Vasc Interv Radiol; 2013 Nov; 24(11):1613-22. PubMed ID: 24060436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemoembolization and bland embolization: a critical appraisal.
    Befeler AS
    Clin Liver Dis; 2005 May; 9(2):287-300, vii. PubMed ID: 15831274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of transarterial chemoembolization with radiofrequency ablation for unresectable Barcelona Clinic Liver Cancer stage 0/A hepatocellular carcinoma: a propensity score matching.
    Chen RX; Gan YH; Ge NL; Chen Y; Ma H; Wang Y; Zhang BH; Wang YH; Ye SL; Luo JF; Ren ZG
    J Gastroenterol Hepatol; 2016 Feb; 31(2):442-9. PubMed ID: 26259976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonsurgical treatment of hepatocellular carcinoma.
    Llovet JM; Sala M; Bruix J
    Liver Transpl; 2000 Nov; 6(6 Suppl 2):S11-5. PubMed ID: 11084079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of hepatocellular carcinoma.
    Yu AS; Keeffe EB
    Rev Gastroenterol Disord; 2003; 3(1):8-24. PubMed ID: 12684589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in non-surgical management of primary liver cancer.
    Chen X; Liu HP; Li M; Qiao L
    World J Gastroenterol; 2014 Nov; 20(44):16630-8. PubMed ID: 25469032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transarterial Chemoembolization versus Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma after Resection within Barcelona Clinic Liver Cancer Stage 0/A: A Retrospective Comparative Study.
    Chen R; Gan Y; Ge N; Chen Y; Wang Y; Zhang B; Wang Y; Ye S; Ren Z
    J Vasc Interv Radiol; 2016 Dec; 27(12):1829-1836. PubMed ID: 27553917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Locally ablative therapies of hepatocellular carcinoma].
    Sturm JW; Keese MA; Bönninghoff RG; Wüstner M; Post S
    Onkologie; 2001 Sep; 24 Suppl 5():35-45. PubMed ID: 11600811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aggressive therapeutic strategies improve the survival of hepatocellular carcinoma patients with performance status 1 or 2: a propensity score analysis.
    Hsu CY; Liu PH; Lee YH; Hsia CY; Huang YH; Chiou YY; Tsai YJ; Nagaria TS; Huo TI
    Ann Surg Oncol; 2015 Apr; 22(4):1324-31. PubMed ID: 25326394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Primary liver and bile duct tumors: approach to conservative therapy].
    Henne-Bruns D; Marks HG
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():343-7. PubMed ID: 9931637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.